Post-approval studies (Phase 4)Study completedNCT01394991
What this trial is testing
A Safety Study of Epoetin Alfa in Patients With Cancer Who Have Chemotherapy-Related Anemia
Who this might be right for
AnemiaNeoplasms
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 504